SureTrader Advertisement PRTC
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 5/31/2016 9:12:15 PM - Followers: 1297 - Board type: Free - Posts Today: 25

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
Announced FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#201693  Sticky Note AMARIN: http://finance.yahoo.com/news/amarin-announces-fda-chemical-entity-173000802.html north40000 05/31/16 02:27:24 PM
#201684  Sticky Note TEVA receives CRL on HD drug acquired from ASPX: DewDiligence 05/31/16 10:47:26 AM
#201681  Sticky Note STEM -81%(!) on plan to liquidate following trial failure: DewDiligence 05/31/16 10:36:41 AM
#201680  Sticky Note JAZZ acquires CPXX for $30.25/sh in cash—a 73% DewDiligence 05/31/16 10:28:35 AM
#201678  Sticky Note ARIAD Announces Initiation of Phase 1/2 Clinical Trial puravida 05/31/16 09:52:57 AM
#201655  Sticky Note GILD’s TAF scam: DewDiligence 05/29/16 12:14:13 PM
#201700   Does anyone have an opinion on PVCT? I ronpopeil 05/31/16 09:12:15 PM
#201699   It's possible (probable?) that ENTA's cyclophilin inhibitor also DewDiligence 05/31/16 06:16:45 PM
#201698   Not to be confused with ENTA’s cyclophilin inhibitor dewophile 05/31/16 06:09:47 PM
#201697   BioMarin intends to discontinue clinical and regulatory development ronpopeil 05/31/16 04:10:43 PM
#201696   RVNC prediction: $15.41 on 5/10/16 will be the DewDiligence 05/31/16 03:17:21 PM
#201695   True...and meantime the indicated uses for Vascepa continue north40000 05/31/16 03:07:31 PM
#201694   AMRN—As it turns out, the FDA delay in DewDiligence 05/31/16 02:56:27 PM
#201693   AMARIN: http://finance.yahoo.com/news/amarin-announces-fda-chemical-entity-173000802.html north40000 05/31/16 02:27:24 PM
#201692   re: PRTO (Proteon) bladerunner1717 05/31/16 02:10:29 PM
#201690   Carl Icahn acquires 'large position' in Allergan, backs CEO http://reuters.com Titan V 05/31/16 11:59:19 AM
#201689   It makes me every happy to see that vinmantoo 05/31/16 11:47:57 AM
#201688   It's not just Sci-Hub. Also Library Genesis (libgen). OakesCS 05/31/16 11:14:10 AM
#201687   Daiichi Sankyo phase-3 fails in NSCLC: DewDiligence 05/31/16 11:02:41 AM
#201686   CTRV acquires HBV cyclophilin inhibitor from private company: DewDiligence 05/31/16 10:59:47 AM
#201685   LLY/B-I—FDA approves Jentadueto, a qD single-tablet combination of DewDiligence 05/31/16 10:57:30 AM
#201684   TEVA receives CRL on HD drug acquired from ASPX: DewDiligence 05/31/16 10:47:26 AM
#201683   Recent Biotech Buyouts of Publicly Traded Companies DewDiligence 05/31/16 10:42:56 AM
#201682   Recent Biotech Bankruptcies, Liquidations, and Dissolutions DewDiligence 05/31/16 10:39:31 AM
#201681   STEM -81%(!) on plan to liquidate following trial failure: DewDiligence 05/31/16 10:36:41 AM
#201680   JAZZ acquires CPXX for $30.25/sh in cash—a 73% DewDiligence 05/31/16 10:28:35 AM
#201679   NTEC receives $5.2 million grant bladerunner1717 05/31/16 10:19:37 AM
#201678   ARIAD Announces Initiation of Phase 1/2 Clinical Trial puravida 05/31/16 09:52:57 AM
#201677   Stolen research papers going almost mainstream? swampboots 05/31/16 08:54:46 AM
#201676   Add also the REGN-NTLA deal. agree, both companies lgonber 05/31/16 06:17:54 AM
#201673   Jazz nearing buyout of cpxx for over $1.5 billion ronpopeil 05/30/16 10:03:16 PM
#201672   The only exceptions to the Bio IPO market jbog 05/30/16 04:00:14 PM
#201671   I should know, but don't know, when any north40000 05/30/16 03:57:45 PM
#201670   I can't see any of these actions being jbog 05/30/16 02:21:21 PM
#201669   MRUS closed @7.62...wow. It’s a tough market out DewDiligence 05/30/16 12:21:59 PM
#201668   MRUS > closed @ 7.62....wow. biocqr 05/30/16 12:18:44 PM
#201667   GILD—You seem surprised. This is an everyday occurrence DewDiligence 05/30/16 11:00:29 AM
#201666   ELTP is running in the same situation. Approval Moose45 05/30/16 10:55:16 AM
#201665   It is up to a private enterprise and caravon 05/30/16 10:29:33 AM
#201664   Redshirt Pharming haysaw 05/29/16 11:07:53 PM
#201662   GILD held off on filing certain TAF patents. jbog 05/29/16 05:56:15 PM
#201661   GILD—Would that delay not open a window for DewDiligence 05/29/16 04:39:56 PM
#201660   Would that delay not open a window for backstroke_ 05/29/16 03:53:04 PM
#201659   GILD held off on filing certain TAF patents. DewDiligence 05/29/16 01:31:03 PM
#201658   >>delayed the issuance of TAF patents biomaven0 05/29/16 01:28:19 PM
#201657   By not developing TAF right away, GILD delayed DewDiligence 05/29/16 01:19:43 PM
#201656   >>GILD's long delay in bringing TAF to market biomaven0 05/29/16 01:17:11 PM
#201655   GILD’s TAF scam: DewDiligence 05/29/16 12:14:13 PM
#201654   FDA Grants Accelerated Approval to Ocaliva™ (Obeticholic Acid) jbog 05/28/16 11:10:15 AM
#201653   Novo Nordisk issues semaglutide Phase 3 clinical trial jbog 05/28/16 09:25:57 AM
#201652   TMO has been of a buying lately primarily jbog 05/27/16 08:01:59 PM
#201651   so are u saying tmo is a brother linhdtu 05/27/16 06:59:38 PM
#201650   BIIB/ABBV—FDA approves Zinbryta (daclizumab) for MS: DewDiligence 05/27/16 06:17:37 PM
#201649   Washington State Medicaid must cover all HCV patients, DewDiligence 05/27/16 05:53:34 PM
#201648   CYCC implements 1:12 reverse split: DewDiligence 05/27/16 05:23:42 PM
#201647   Rolling is the key word there, LOL. DewDiligence 05/27/16 03:58:29 PM
PostSubject